87 related articles for article (PubMed ID: 6231779)
1. [Efficacy and tolerance of hepatitis B vaccination in medical personnel and hemodialysis patients].
Horak W; Leithner C; Kemenesi W; Pinggera W
Wien Klin Wochenschr; 1984 Feb; 96(4):161-5. PubMed ID: 6231779
[TBL] [Abstract][Full Text] [Related]
2. [Experiences with vaccination against hepatitis B].
Kunz C; Hofmann H; Frisch-Niggemeyer W
Wien Klin Wochenschr; 1984 Feb; 96(4):158-61. PubMed ID: 6231778
[TBL] [Abstract][Full Text] [Related]
3. The safety and efficacy of GM-CSF as an adjuvant in hepatitis B vaccination of chronic hemodialysis patients who have failed primary vaccination.
Evans TG; Schiff M; Graves B; Agosti J; Barritt ML; Garner D; Holley JL
Clin Nephrol; 2000 Aug; 54(2):138-42. PubMed ID: 10968690
[TBL] [Abstract][Full Text] [Related]
4. Immune response to a heat-inactivated hepatitis B vaccine in patients undergoing hemodialysis. Enhancement of the response by increasing the dose of hepatitis B surface antigen from 3 to 27 micrograms.
Lelie PN; Reesink HW; de Jong-van Manen ST; Dees PJ; Reerink-Brongers EE
Arch Intern Med; 1985 Feb; 145(2):305-9. PubMed ID: 3977491
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B vaccine: clinical trials in high-risk settings in France. (September 1975-September 1982).
Goudeau A; Dubois F; Barin F; Dubois MC; Coursaget P
Dev Biol Stand; 1983; 54():267-84. PubMed ID: 6228468
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of vaccination against hepatitis B in adult with HIV infection].
Kalinowska-Nowak A; Bociaga-Jasik M; Garlicki A; Mach T
Przegl Epidemiol; 2007; 61(2):339-47. PubMed ID: 17956052
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and long-term immunogenicity of hepatitis B vaccine in haemodialysis patients.
Ramezani A; Eslamifar A; Banifazl M; Ahmadi F; Maziar S; Razeghi E; Kalantar E; Amirkhani A; Aghakhani A
Int J Clin Pract; 2009 Mar; 63(3):394-7. PubMed ID: 18005039
[TBL] [Abstract][Full Text] [Related]
8. [Hepatitis B vaccination].
Descoeudres C
Schweiz Med Wochenschr; 1984 Apr; 114(15):498-505. PubMed ID: 6729415
[TBL] [Abstract][Full Text] [Related]
9. The evaluation of immune responses that occur after HBV infection and HBV vaccination in hemodialysis patients.
Kara IH; Yilmaz ME; Suner A; Kadiroglu AK; Isikoglu B
Vaccine; 2004 Sep; 22(29-30):3963-7. PubMed ID: 15364445
[TBL] [Abstract][Full Text] [Related]
10. [Vaccination against hepatitis B in a hemodialysis unit. A 4-year follow up (author's transl)].
Pengloan J; Bagros P; Jourdan JL; Nivet H; Goudeau A; Dubois F; Barin F
Nephrologie; 1982; 3(1):32-5. PubMed ID: 7088262
[TBL] [Abstract][Full Text] [Related]
11. [Hepatitis B vaccination with the plasma-derived Hevac-B Pasteur vaccine. A comparison of 2 populations: hospital personnel and hemodialysis patients].
Di Giandomenico G; Di Giandomenico FW; Volterrani A
Minerva Med; 1989 Feb; 80(2):149-51. PubMed ID: 2927706
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and safety of heat-inactivated hepatitis B vaccine (CLB) in low risk human volunteers and in patients treated with chronic haemodialysis in the Netherlands.
Reerink-Brongers EE; Lelie PN; Reesink HW; Dees PJ; Brummelhuis HG; van Aken WG
Dev Biol Stand; 1983; 54():197-203. PubMed ID: 6228459
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B in haemodialysis: vaccination against HBS antigen.
Crosnier J
Proc Eur Dial Transplant Assoc; 1981; 18():231-40. PubMed ID: 7036150
[TBL] [Abstract][Full Text] [Related]
14. Active hepatitis B immunization with an experimental German vaccine. I. Immunogenicity studies in healthy adults. II. The primary 19 S and 7 S responses to HBsAg in healthy adults. III. Immunogenicity studies in hemodialysis patients.
Scheiermann N; Kuwert EK
Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Aug; 257(3):439-55. PubMed ID: 6485639
[TBL] [Abstract][Full Text] [Related]
15. Response to the hepatitis B virus vaccine in haemodialysis patients: influence of malnutrition and its importance as a risk factor for morbidity and mortality.
Fernández E; Betriu MA; Gómez R; Montoliu J
Nephrol Dial Transplant; 1996 Aug; 11(8):1559-63. PubMed ID: 8856211
[TBL] [Abstract][Full Text] [Related]
16. Preliminary results of hepatitis B vaccination (HEVAC B) in healthy subjects and haemodialysis patients.
van Beers D; Liesnard C; Duys M; Etienne J; Cappel R
Dev Biol Stand; 1983; 54():163-9. PubMed ID: 6228455
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy.
Stevens CE; Alter HJ; Taylor PE; Zang EA; Harley EJ; Szmuness W
N Engl J Med; 1984 Aug; 311(8):496-501. PubMed ID: 6235453
[TBL] [Abstract][Full Text] [Related]
18. Clinical experience with a new recombinant hepatitis-B vaccine in previous non-responders with chronic renal insufficiency.
Haubitz M; Ehlerding G; Beigel A; Heuer U; Hemmerling AE; Thoma HA
Clin Nephrol; 1996 Mar; 45(3):180-2. PubMed ID: 8706359
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of prophylactic vaccination against Hepatitis B Virus infection viruses in hemodialyzed patients].
Urbanowicz W
Przegl Epidemiol; 2000; 54(3-4):343-50. PubMed ID: 11349597
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B vaccination in haemodialysis patients: a randomized clinical trial.
Bock M; Barros E; Veronese FJ
Nephrology (Carlton); 2009 Apr; 14(3):267-72. PubMed ID: 19207871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
